Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
Nature|March 26, 2026
Oxygen supply through the tracheolar-muscle system does not constrain insect gigantismEdward P Snelling, Antonia V Lensink, Susana Clusella-Trullas, et al.
Integrative and Comparative Biology|June 14, 2011
Episodes in insect evolutionTimothy J Bradley, Adriana D Briscoe, Seán G Brady, et al.
Integrative and Comparative Biology|August 6, 2022
White Paper: An Integrated Perspective on the Causes of Hypometric Metabolic Scaling in AnimalsJon F Harrison, Andrew Biewener, Joanna R Bernhardt, et al.
Medrxiv : the Preprint Server for Health Sciences|April 3, 2026
Enhancing, controlling, and sterilizing dengue immunity and the development of broadly protective responsesCamila D Odio, Rosemary A Aogo, Saba Firdous, et al.
The Journal of Infectious Diseases|April 24, 2024
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to RemdesivirKanal Singh, Kevin Rubenstein, Viviane Callier, et al.
Lancet (London, England)|April 26, 2026
Safety and efficacy of the monoclonal antibody L9LS for malaria prevention in children exposed to perennial malaria transmission in Kenya: a randomised, double-blind, placebo-controlled, phase 2 trialLaura C Steinhardt, Titus K Kwambai, Martina Oneko, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
Comparison of Four Assays That Measure Antibodies to Ebola Virus GlycoproteinIrina Maljkovic Berry, Safaa Ben Farhat, Viviane Callier, et al.
Integrative and Comparative Biology|July 9, 2024
Insect Flight: State of the Field and Future DirectionsLisa A Treidel, Kevin D Deem, Mary K Salcedo, et al.
Biorxiv : the Preprint Server for Biology|April 29, 2026
Intranasal Replicating Adenovirus type 4-SARS-CoV-2 Recombinants Induce Superior Immune Response Durability and Efficacy in Preclinical Testing Compared to Standard Intramuscular VaccinesBreanna Kim, Rachel Roenicke, Peyton M Roeder, et al.
Iscience|April 20, 2026
Intranasal replicating adenovirus type 4-vectored SARS-CoV-2 vaccines induce durable and efficacious responses in preclinical testingBreanna Kim, Rachel Roenicke, Peyton M Roeder, et al.
Pageof 20